Ginkgo Bioworks

Making biology easier to engineer.

Founded 2009

Boston, United States 487 employees Total: $2.55B Biopharma, Biotechnology

General Information

Company Name Ginkgo Bioworks

Founded Year 2009

Location

Boston, United States

Employees 487

Industries Biopharma, Biotechnology

Business Model B2B, Platform, SaaS

Revenue Model Usage Based, Service Fee, Project Based

Offices as of Oct 2026

Boston, United States Cambridge, United States Emeryville, United States CH , The Netherlands

Social

BounceWatch is an independent company data service, not affiliated with Ginkgo Bioworks. To contact Ginkgo Bioworks, visit ginkgobioworks.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ginkgo Bioworks compare?

A PDF of Ginkgo Bioworks and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ginkgo Bioworks soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 06, 2026

Ginkgo will participate as an exhibitor at Future Labs Live from October 28–29, 2026 in Philadelphia.

Major Customer Win Sep 29, 2026

Ginkgo Bioworks secured AbbVie, argenxglobal, LundbeckUS, and TakedaPharma as founding members for its new Antibody Developability Consortium.

New Partnership Sep 23, 2026

Ginkgo Bioworks has announced a partnership with Endeavor to integrate Endeavor's biological data generation into an autonomous lab platform.

Feature Release Sep 18, 2026

Ginkgo Bioworks has launched a new feature, DJ Nebula, allowing its autonomous lab instruments to be turned into MIDI instruments to create musical tracks.

Grant Received Sep 10, 2026

Ginkgo Bioworks was awarded a subcontract for up to $17.5M under the ARPA-H GIVE program from the Advanced Research Projects Agency for Health.

Get alerts when Ginkgo Bioworks shows new signals

AI Insight

Bounce Watch AI

1 month ago

Ginkgo Bioworks is demonstrating significant strategic momentum, actively expanding its ecosystem and validating its advanced autonomous lab capabilities. Recent highlights include a key partnership with MIT Media Lab, the launch of a new service facilitating reagent integration for automated labs, and a major customer win with the Department of Energy commissioning their AMP2 lab. These actions signal a clear strategic shift towards broadening platform adoption through both direct client engagement and strengthening its supplier network.

Signal Types

Partnership Product Launch Customer Acquisition Recognition Efficiency Gain

Strategic Labels

Ecosystem Expansion Technology Validation Market Penetration

Next Move: Expansion

Impact: 8/10

Ideal For: Biotechnology Growth Investors – Public Equity

About Ginkgo Bioworks

Ginkgo Bioworks is pioneering advancements in the field of biotechnology by making biology easier to engineer, fulfilling its promise embodied in the slogan, "Making biology easier to engineer." Founded in 2009, this United States-based company operates at the intersection of Biopharma and Biotechnology.

By leveraging autonomous laboratories, Ginkgo Bioworks aims to revolutionize traditional laboratory processes through robotics, enhancing the productivity of scientists. Its innovative solutions, accessible via the "cloud lab" model, provide advanced Datapoints and Solutions contract research services, making lab operations more efficient and streamlined.

The company recently secured a Grant investment on 01 April 2024 from the Bill & Melinda Gates Foundation, highlighting confidence from major investors in its mission and technological acumen.

Taxonomy: Biological Engineering, Synthetic Biology, Automation in Laboratories, Cloud Lab Services, Custom Microbes, Molecular Discovery, Probiotic Development, Organism Licensing, Flavor and Sweetener Engineering, Cosmetic Ingredient Design, Crop Treatment Solutions, Pharmaceutical Applications, Carbon Mitigation, Metabolic Engineering, AI in Biotechnology

Services & Products

Building Autonomous Labs

Providing Cloud Lab Services

R&D Experiment Design

Ginkgo Solutions Team

Ginkgo Datapoints Services

Target Customers

Scientists Biotech Researchers Pharmaceutical Companies Biotech Startups R&D Professionals

Funding Rounds & Investors (21)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	Undisclosed	1	Bill & Melinda Gates Foundation	01 Apr 2024
Support Program	$5.21M	1	DARPA	01 Jan 2024
Grant	Undisclosed	1	National Institute of Food and Agriculture	01 Sep 2023
Post-IPO Equity	$15.86M	1	Ark Invest	01 Oct 2021
Spac Private Placement	$1.73B	1	Soaring Eagle Acquisition Corp	01 May 2021
Support Program	$5.89M	1	DARPA	01 Sep 2020
Late VC	$70.00M	3	General Atlantic, Viking Global Investors +1	01 May 2020
Series E	$290.00M	3	General Atlantic, Viking Global Investors +1	01 Sep 2019
Series D	$275.00M	5	Y Combinator, General Atlantic +3	01 Dec 2017
Support Program	$10.45M	1	DARPA	01 Sep 2017

View All 21 Funding Rounds

Latest News

View All

GM hires ex-Tesla, Google exec to replace retiring head of manufacturing

Cnbc Mar 14, 2024

Ginkgo Bioworks Alternatives & Competitors

View All Alternatives

Ginkgo Bioworks vs

Discover Echo Inc. United States

Experience Precision in Biological Research with Advanced Automated Microscopy for Accurate Imaging...

Series A

68 employees

Biopharma, Biotechnology

Compare Ginkgo Bioworks vs Discover Echo Inc.

Ginkgo Bioworks vs

Alpha Genesis Inc. United States

Full-Service Nonhuman Primate Research Solutions

104 employees

Biopharma, Biotechnology

Compare Ginkgo Bioworks vs Alpha Genesis Inc.

Ginkgo Bioworks vs

BDD United Kingdom

Redefining Early Stage Development

Venture round

54 employees

Biopharma, Biotechnology

View all alternatives

FAQ About Ginkgo Bioworks

Making biology easier to engineer.

Ginkgo Bioworks was founded in 2009.

Ginkgo Bioworks is headquartered in Boston, United States. As of Oct 2026, it also has offices in Cambridge, United States, Emeryville, United States and CH , The Netherlands.

Ginkgo Bioworks operates in Biopharma and Biotechnology. Its work centres on Biological Engineering, Synthetic Biology, Automation in Laboratories and Cloud Lab Services. Its customers include Scientists, Biotech Researchers and Pharmaceutical Companies.

Ginkgo Bioworks has a B2B, Platform and SaaS business model. Its revenue comes from Usage Based, Service Fee and Project Based.

Ginkgo Bioworks has approximately 487 employees.

Ginkgo Bioworks has completed 21 funding rounds, raising a total of $2.55B.

Ginkgo Bioworks offers: Building Autonomous Labs, Providing Cloud Lab Services, R&D Experiment Design, Ginkgo Solutions Team, Ginkgo Datapoints Services.

Top alternatives and competitors to Ginkgo Bioworks include Discover Echo Inc., Alpha Genesis Inc., BDD, Apostle Inc, Frontier Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Ginkgo Bioworks and Discover Echo Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ginkgo Bioworks, https://bouncewatch.com/company/gingko-bioworks, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Ginkgo Bioworks

General Information

Discover More

What changed at Ginkgo Bioworks recently?

AI Insight

About Ginkgo Bioworks

Services & Products

Target Customers

Funding Rounds & Investors (21)

Latest News

Ginkgo Bioworks Alternatives & Competitors

FAQ About Ginkgo Bioworks